Follow us on Twitter
Follow us on LinkedIn
Follow us on Youtube

MYOCURE

Development of an innovative gene therapy platform to cure rare hereditary muscle disorders


Description

The collaborative research project MYOCURE advances the development of new therapeutic products for patients suffering from rare inherited muscle diseases. The research specifically focuses on myotubular myopathy (MTM) and glycogen storage disorder (GSD) type II. MTM and GSD II are severe, potentially life-threatening rare muscle diseases for which there is no definitive cure and current treatment is suboptimal. MYOCURE explores strategies to overcome the key bottlenecks that hamper muscle-directed gene therapy.

Coordinator
Prof. Marinee Chuah
Vrije Universiteit Brussel (VUB)
Phone: +32 473 215849
Email
Programme
Horizon 2020 & sub-programmes
Duration
48 months (January 2016 - December 2019)
Project funding
€ 5,998,937.50
Project partners
8
Technology readiness level
2-4
About Eurice

Eurice offers knowledge-based consultancy services in project and innovation management.

Eurice Head Office
Heinrich-Hertz-Allee 1
66386 St. Ingbert
Germany
Phone: +49 6894 388130
Email
Eurice Berlin
Alt-Reinickendorf 25
13407 Berlin
Germany
Phone: +49 30 374415840
Email